4.8 Letter

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

Francesca Del Bufalo et al.

Summary: Immunotherapy with GD2-CAR T cells expressing the inducible caspase 9 suicide gene is a feasible and safe treatment option for high-risk neuroblastoma patients, with a sustained antitumor effect and a significant improvement in overall survival and event-free survival.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Immunology

TIM3 comes of age as an inhibitory receptor

Yochai Wolf et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion

Lyndsay Avery et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Immunology

T cell exhaustion

E. John Wherry

NATURE IMMUNOLOGY (2011)

Article Immunology

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)